Industry Insight
Discovery Technology
Analytical Laboratory Technology
Delivery Systems
Ingredients, Formulation and Finishing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
   Or select

Or become a subscriber

Innovations in Baculovirus Protein Expression

For the pharmaceutical industry, the cost-effective expression of proteins as putative drug targets for study as therapeutics, or to aid in the development of diagnostics, presents many difficulties.

Dr Kevin Richards and Dr Grant Cameron, NextGen Sciences (April 2006)

Keywords: cost-effective expression of proteins putative drug targets therapeutics diagnostics difficulties

    View full article    |    Back to Bioprocessing section

Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |